TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health

    The Michael J. Fox Foundation Parkinson’s Podcast

    Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations that include the voices of those affected by Parkinson’s as well as clinicians.

    Advertise

    Copyright: © Copyright 2013

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl Sep 03, 2024
    Show notes

    Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanopsin cells, provide the main light signals to the brain to initiate sleep, and function of these cells is impaired in PD. Dr. Beatix Feigl and her colleagues developed a novel light therapy intervention that selectively activates the melanopsin photoreceptor cells, and in this episode, she discusses the results of a recent randomized controlled trial evaluating the efficacy of this melanopsin photoreceptor-directed light therapy on sleep and circadian rhythm, as well as motor behaviors. She also discusses her earlier work on melanopsin cells that led to the development of standard measures to assess their function. Beatrix is an Ophthalmologist and an Associate Professor in the School of Biomedical Sciences and Center for Vision and Eye Research, as well as the Faculty of Health, at the Queensland University of Technology.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit

    This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.


    Your Daily Dose: Managing Parkinson’s Medications (Webinar Audio) Aug 21, 2024
    Show notes

    Finding the right Parkinson’s treatment plan can be a trial-and-error process. The kind of medication, the dosage, the timing and lifestyle factors are all important pieces of the puzzle. In audio from this Third Thursdays Webinar, our expert panel made up of people living with Parkinson’s disease (PD), a movement disorder specialist and a researcher discuss different medication options, practical tips for finding what works best for you and the latest research on emerging treatments.

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

    The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue Aug 20, 2024
    Show notes

    Though existing evidence supports that dysfunction in the clearing of cellular debris plays an important role in the development of Parkinson's disease, many unanswered questions remain regarding the mechanisms of the autophagy-lysosomal pathway involved in this process. In particular, research in the field has been limited by a lack of reliable, quantitative tests for monitoring autophagy-lysosome activity. In this interview, Dr. Zhenyu Yue describes his research investigating the cellular and molecular mechanisms for Parkinson's disease and other neurodegenerative diseases, focusing on their work examining the regulation of the autophagy-lysosomal pathway, potential therapeutic targets, and MJFF-funded research that aims to develop sensitive, robust autophagy-lysosome assays to facilitate the discovery of biomarkers for PD using stem cell-derived neurons and biofluids. Zhenyu is the Aidekman Research Professor in the Department of Neurology and Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. He is also the Director of the Center of Parkinson’s Disease Neurobiology and Director of Basic Research of Movement Disorders at Mount Sinai.

    Mentioned in this episode:

    This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Breathing Through: Mindfulness as a Parkinson's Treatment Tool Aug 14, 2024
    Show notes

    Research shows mindfulness and meditation can improve some Parkinson’s (PD) symptoms and help people live a better life with the disease, but it can be tricky to put into practice. In this podcast, you’ll hear from people whose lives have been touched by PD and who use mindfulness to reduce symptoms and stress, and from a researcher who is studying how mind-body strategies can be used to treat Parkinson’s. Tune in for practical tips, advice and a guided meditation you can try at home.

    You can find links to the resources mentioned in the episode on our website: michaeljfox.org/podcast/breathing-through-mindfulness-parkinsons-treatment-tool

    You can also download our free guide on exercise and Parkinson’s disease, which includes tips for incorporating meditation into your daily routine at michaeljfox.org/exerciseguide

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor Aug 06, 2024
    Show notes

    Evidence supports that dysfunction in the homeostasis of iron and other elements likely contributes to the pathophysiological mechanisms of Parkinson's disease, but we have yet to develop suitable elemental biomarkers for use in diagnosing and monitoring the progression of Parkinson's disease. Dr. Paul Lingor discusses his work in this area to identify patterns of bioelements in CSF that could serve as PD biomarkers. Beyond CSF, he is also examining tear fluid as a potential biomarker source that is easier to collect. In addition to work on biomarkers, Paul has been involved in developing and evaluating new treatments for Parkinson's disease. In this episode, he discusses an ongoing phase II clinical trial evaluating the ROCK inhibitor Fasudil, as well as research examining combinations of advanced therapies for people with later-stage Parkinson's disease. Paul is Professor of Neurology at the Technical University of Munich and head of the outpatient clinics for motor neuron disease and co-head of the outpatient clinics for Parkinson’s disease.

    Mentioned in this episode:

    This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Considering Deep Brain Stimulation: What to Know and Expect (Webinar Audio) Jul 24, 2024
    Show notes

    The decision-making process around deep brain stimulation (DBS) to treat Parkinson’s motor symptoms can be a complex and emotional journey. People often have questions about when – and whether – to have the procedure and what the experience is like, from the months of evaluation pre-surgery to surgery day to life with the device. In audio from this Third Thursdays Webinar, our panel of people living with Parkinson’s disease (PD) and a movement disorder specialist share their DBS stories and answer audience questions about their choices and experiences.

    Learn more about deep brain stimulation and download our free guide on our website: https://bit.ly/4cTOT52

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your community.

    The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella Jul 23, 2024
    Show notes

    Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical parkinsonism would have substantial impacts on clinical trials and clinical practice. A particularly active area of research is the development of novel molecular imaging biomarkers that can be used in combination with common neuroimaging approaches. Dr. Antonio Strafella discusses current practices for using molecular imaging biomarkers in research and in the clinic, the process of developing new biomarkers, as well as promising biomarkers that are in development. He also discusses limitations, implementation challenges, and the potential use of AI to enhance diagnostics in the future. Antonio is the Krembil-Rossy Chair in Molecular Imaging of Neurodegenerative Diseases and Professor in the Department of Medicine within the Division of Neurology at the Toronto Western Hospital (University Health Network, University of Toronto). He also serves as Director of Clinical Research and Translation with the Temerty Faculty of Medicine at the University Toronto, and he is a movement disorder neurologist in the Edmond J. Safra Program in Parkinson’s Disease and Morton & Gloria Shulman Movement Disorders Clinic at the Toronto Western Hospital.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit

    This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.


    Building on the Biomarker Breakthrough: What We’re Working on Now Jul 10, 2024
    Show notes

    Just over a year ago, there was a major breakthrough in Parkinson’s disease (PD) research – a tool that could detect abnormal alpha-synuclein protein in the spinal fluid of people living with PD even before onset of symptoms. This discovery is already impacting the ways scientists conduct and think about Parkinson’s research. Tune into this episode of our award-winning “Parkinson’s Science POV” series to learn how researchers are using the test to better understand disease biology and what the future holds.

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

    The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Examining Links Between Environmental Exposure, Poor Olfaction, and Parkinson's Disease with Honglei Chen Jul 09, 2024
    Show notes

    Prior studies have established links between poor olfaction and Parkinson's disease, and impaired sense of smell is a common prodromal symptom of Parkinson's disease. The causes and mechanisms of prodromal neurodegeneration are actively being researched. However, environmental exposure to pesticides or other chemicals may trigger or modify the course of neurodegeneration, potentially leading to the development of Parkinson's disease over time. In this episode, Dr. Honglei Chen shares his research on environmental causes of neurodegenerative diseases, focusing particularly on evidence linking olfaction, environmental exposure, and Parkinson’s disease. Better understanding how environmental factors may contribute (alone or in combination with genetic factors) to the pathogenesis of Parkinson's disease may lead to new approaches to prevent or slow the progression of neurodegeneration. Honglei is the MSU Research Foundation Professor of Epidemiology and Biostatistics at Michigan State University.

    Mentioned in this episode:

    This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    You Want to Volunteer for Parkinson’s Research: Now What? (Webinar Audio) Jun 26, 2024
    Show notes

    You might be interested in stepping forward for science to play a role in the next breakthrough in Parkinson’s research, but still have questions about how to actually participate. How do you pick the right study for you? How do you balance your life logistics and your medical care considerations? What rights do you have when you participate in a study? In audio from this Third Thursdays Webinar, our panel of people living with Parkinson’s and research experts discuss the practicalities and benefits of volunteering for research.

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

    The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

    Mentioned in this episode:

    All Grit. No Quit. is our bold Campaign to raise $2.5 billion by 2028. This is our biggest push yet toward a world without Parkinson's and we need to bring the full force of our community to meet this moment. Whatever brings you here, you can be a part of accelerating what comes next. michaeljfox.org/campaign/all-grit-no-quit


    Previous 1 5 6 7 8 9 28 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    Casefile True Crime

    2

    Casefile True Crime Games & Hobbies
    Reply All

    3

    Reply All Games & Hobbies
    Good Life Project

    4

    Good Life Project Education
    Happier with Gretchen Rubin

    5

    Happier with Gretchen Rubin Health
    The Other F Word: Conversations About Failure

    6

    The Other F Word: Conversations About Failure Health
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights